Dachaigh › Cardiomyopathy Hypertrophic › Missouri
Sgrùdaidhean clionaigeach Cardiomyopathy Hypertrophic ann an Missouri
Tha 3 sgrùdaidhean airson Cardiomyopathy Hypertrophic a’ lorg phàirtichean aig làraichean ann an Missouri.
Teacsa sgrùdaidh oifigeil (Beurla)
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- St. Luke's Mid-America Heart Institute, Kansas City
- Washington University, St Louis
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT05489705Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic Cardiomyopathy
- St. Luke's Hospital - Mid America Heart Institute, Kansas City
A’ fastadhÌre 4
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT07600177A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, St Louis
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Cèit 2026 · NCT07023614Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.